IDEAS home Printed from
MyIDEAS: Log in (now much improved!) to save this article

The Production Of Medicines In Romania After 1990. What'S The Reason For Imports?

Listed author(s):
  • Unita Lucian


    (University of Oradea, Faculty of Medicine and Pharmacy)

  • Straciuc Oreste

    (University of Oradea, Faculty of Medicine and Pharmacy)

  • Maghiar Teodor Traian

    (University of Oradea, Faculty of Medicine and Pharmacy)

  • Uivarosan Diana

    (University of Oradea, Faculty of Medicine and Pharmacy)

Registered author(s):

    Since 1990, Romania turned itself slowly but surely, from a large drugs producer, which has used to supplydrugs to the whole former Council for Mutual Economic Assistance Member States, and with a net positive trade balance in medicine sector, into a large drugs importer, trying hardly to attract investors which could produce medicines not only for the Romanian domestic market, but also for all other Eastern European markets, Ukraine, Russia and Turkey. This paper focuses on the empirical analisys of the medicines production sector in Romania after 1990, aiming to emphasises the factors which have mostly affected this industry, in correlation with different interests and reasons which determined the increasing imports of drugs during the last years, by underlying at the same time, the role of the new public authority in charge of supervising the distribution and import of medicines in Romania, The National Medicines Administration (NMA). The paper relevance relies in the fact that Romania registered during the last years drug imports of an average of 1.7 billion euros, while the drug exports were only around 0,1 billions euros, according to the computations made on the data provided by the Romanian Institute of National Statistics (INS). The most imported products are patent drugs, which are more expensive than those produced by the domestic manufactured. At the same time, Romania registered an increase of the pharmaceutical market of around 20% only since its EU integration, this market proven to be largely driven by expensive products. Our research conducted to the conclusion that the Romanian resort authorities have to immediately adopt measures meant to limit consumption of expensive drugs, on the one side, and to reinforce the domestic manufacturers on the other side, even by attracting major investors in this sector. We have also identified that there is a large competitiveness for Romanian medicine products on the international market, due to its production costs (Romania still is a low cost economy in this sector), as well as due to its tradition.

    If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.

    File URL:
    Download Restriction: no

    Article provided by University of Oradea, Faculty of Economics in its journal The Annals of the University of Oradea. Economic Sciences.

    Volume (Year): 1 (2011)
    Issue (Month): 2 (December)
    Pages: 124-130

    in new window

    Handle: RePEc:ora:journl:v:1:y:2011:i:2:p:124-130
    Contact details of provider: Postal:
    Universitatii str. 1, Office F209, 410087 Oradea, Bihor

    Phone: +40259408799
    Fax: 004 0259 408409
    Web page:

    More information through EDIRC

    References listed on IDEAS
    Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:

    in new window

    1. Adriana Giurgiu, 2008. "The Leading Economic Sectors Building Comparative and Competitive Advantages in Romania's Foreign Trade," Theoretical and Applied Economics, Asociatia Generala a Economistilor din Romania - AGER, vol. 5(5(522)), pages 11-44, May.
    2. GIURGIU Adriana, 2010. "An Overview Of The General Evolution Of The Romanian Foreign Trade After 1989, While Trying To Join The Eu (Ii)," Annals of Faculty of Economics, University of Oradea, Faculty of Economics, vol. 1(2), pages 100-106, December.
    Full references (including those not matched with items on IDEAS)

    This item is not listed on Wikipedia, on a reading list or among the top items on IDEAS.

    When requesting a correction, please mention this item's handle: RePEc:ora:journl:v:1:y:2011:i:2:p:124-130. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Catalin ZMOLE)

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If references are entirely missing, you can add them using this form.

    If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    This information is provided to you by IDEAS at the Research Division of the Federal Reserve Bank of St. Louis using RePEc data.